US Stock MarketDetailed Quotes
LPTX Leap Therapeutics
- 2.9200
- +0.2700+10.19%
Close Nov 27 16:00 ET
- 2.9100
- -0.0100-0.34%
Post 20:01 ET
111.89MMarket Cap-1780P/E (TTM)
3.0600High2.5900Low383.07KVolume2.7100Open2.6500Pre Close1.10MTurnover1.48%Turnover RatioLossP/E (Static)38.32MShares5.000052wk High2.28P/B75.62MFloat Cap1.680052wk Low--Dividend TTM25.90MShs Float102.5000Historical High--Div YieldTTM17.74%Amplitude1.2350Historical Low2.8780Avg Price1Lot Size
Leap Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -48.74%-15.6M | -34.23%-13.67M | -22.17%-15.52M | 10.79%-43.75M | 20.24%-10.38M | 14.40%-10.49M | 16.92%-10.19M | -10.26%-12.7M | -39.50%-49.04M | -21.44%-13.01M |
| Net income from continuing operations | -32.71%-18.18M | -50.32%-20.13M | 66.99%-13.82M | -49.12%-81.41M | -3.00%-12.47M | 9.26%-13.7M | 21.35%-13.39M | -303.46%-41.86M | -34.52%-54.6M | -12.18%-12.1M |
| Operating gains losses | -98.40%8K | -103.08%-6K | -93.77%16K | -97.86%13K | -34.86%-940K | -37.92%501K | -73.40%195K | 209.36%257K | 60.42%608K | -2,148.39%-697K |
| Depreciation and amortization | -1.51%-202K | -1.94%202K | 25.00%5K | -6.25%15K | 0.00%4K | 1.49%-199K | 94.34%206K | -96.30%4K | -44.83%16K | -50.00%4K |
| Other non cash items | ---- | ---- | -99.66%100K | 7,417.29%29.99M | 324.74%412K | --0 | ---100K | --29.68M | -24.29%399K | -53.59%97K |
| Change In working capital | -10.90%1.43M | 204.51%4.99M | -46.65%-3.07M | 485.71%2.51M | 176.48%1.36M | 135.83%1.61M | -38.38%1.64M | 5.81%-2.09M | -164.26%-651K | -68.54%-1.77M |
| -Change in receivables | -73.14%498K | 15.49%-251K | 11.15%-247K | 229.04%1.3M | 102.89%23K | 335.21%1.85M | 50.50%-297K | -631.58%-278K | 12.94%-1.01M | -291.13%-797K |
| -Change in prepaid assets | -5.23%145K | 2.96%174K | -43.51%-343K | -60.58%164K | 138.24%81K | 232.61%153K | 186.44%169K | -186.28%-239K | 165.10%416K | 106.16%34K |
| -Change in payables and accrued expense | 195.19%594K | 179.66%5.07M | -8.65%-2.39M | -24.66%712K | 240.59%1.72M | -141.94%-624K | -40.47%1.81M | 7.26%-2.2M | -75.77%945K | -25.59%-1.22M |
| -Change in other current assets | -8.54%300K | 75.00%98K | -98.76%9K | 199.07%748K | -328.66%-359K | 127.70%328K | -78.13%56K | 4,418.75%723K | -226.47%-755K | -73.70%157K |
| -Change in other current liabilities | -0.95%-106K | 0.00%-103K | 2.00%-98K | -3.75%-415K | -10.31%-107K | -10.53%-105K | -0.98%-103K | 5.66%-100K | 1.48%-400K | 45.20%-97K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 111.88%152K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -48.74%-15.6M | -34.23%-13.67M | -22.17%-15.52M | 10.79%-43.75M | 20.24%-10.38M | 14.40%-10.49M | 16.92%-10.19M | -10.26%-12.7M | -39.50%-49.04M | -21.44%-13.01M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 48.97M | 0 | 0 | -348K | 49.32M | 0 | 0 |
| Net business purchase and sale | --0 | --0 | --0 | --50.36M | --0 | --0 | --0 | --50.36M | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | ---1.39M | --0 | --0 | ---348K | ---1.05M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --48.97M | --0 | --0 | ---348K | --49.32M | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -6,500.00%-66K | 37.12M | 200.00%29K | 85.71%-30K | 0 | -1K | 0 | 86.19%-29K | -100.21%-210K | 0 |
| Net common stock issuance | --0 | ---- | ---- | ---1K | --0 | ---1K | ---- | ---- | --0 | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | 200.00%29K | ---29K | --0 | --0 | --0 | ---29K | --0 | --0 |
| Net other financing activities | ---66K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -14.13%-210K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -6,500.00%-66K | --37.12M | 200.00%29K | 85.71%-30K | --0 | ---1K | --0 | 86.19%-29K | -100.21%-210K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -14.15%78.48M | -46.18%54.92M | 7.85%70.64M | -43.00%65.5M | 3.11%80.74M | 0.59%91.42M | -1.15%102.04M | -43.00%65.5M | 120.69%114.92M | -37.24%78.31M |
| Current changes in cash | -49.36%-15.67M | 322.60%23.45M | -142.33%-15.49M | 110.53%5.19M | 20.24%-10.38M | 14.40%-10.49M | 14.08%-10.53M | 411.97%36.59M | -178.33%-49.25M | -30.65%-13.01M |
| Effect of exchange rate changes | 105.46%10K | 224.44%112K | -370.00%-235K | 73.46%-43K | 35.92%280K | 43.17%-183K | -15.38%-90K | -256.25%-50K | -390.91%-162K | 94.34%206K |
| End cash Position | -22.19%62.82M | -14.15%78.48M | -46.18%54.92M | 7.85%70.64M | 7.85%70.64M | 3.11%80.74M | 0.59%91.42M | -1.15%102.04M | -43.00%65.5M | -43.00%65.5M |
| Free cash flow | -48.74%-15.6M | -34.23%-13.67M | -22.17%-15.52M | 10.79%-43.75M | 20.24%-10.38M | 14.40%-10.49M | 16.92%-10.19M | -10.26%-12.7M | -39.50%-49.04M | -21.44%-13.01M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data